REGULATION OF BBB GLUT1 GLUCOSE TRANSPORTER
BBB GLUT1 葡萄糖转运蛋白的调节
基本信息
- 批准号:6540113
- 负责人:
- 金额:$ 22.16万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-08-01 至 2004-04-30
- 项目状态:已结题
- 来源:
- 关键词:blood brain barrier cell line cerebral ischemia /hypoxia cerebrovascular occlusions disease /disorder model gene induction /repression glucose metabolism glucose receptor glucose transport glucose transporter glycogenesis glycogenolysis immunocytochemistry posttranscriptional RNA processing protein structure function reporter genes tissue /cell culture transfection vascular endothelium vascular endothelium permeability
项目摘要
DESCRIPTION: (Verbatim from the Applicant's Abstract) The principal glucose
transporter at the brain capillary endothelium, which forms the blood-brain
barrier (BBB) in vivo, is the Glut1 isoform of the sodium independent glucose
transporter gene family. Previous studies have demonstrated an important mode
for regulation of BBB Glut1 gene expression is at the post-transcriptional
level in pathophysiologic states such as human brain tumors, glucose
deprivation/hypoglycemia, development, and cerebral ischemia.
Post-transcriptional regulation of mRNA function is mediated via the
interaction of cytosolic or polysome proteins with specific cis-elements
located within either the 5' - or 3' -untranslated region (UTR) of the Glut1
mRNA. Previous studies have described a polysome protein, designated p44, and a
cytosolic protein, designated p88, which interact with two different
cis-elements within the 3'-UTR of the glout1 mRNA. The p88 cis-element is
associated with an increase in Glut1 gene expression and mediates the
stabilization of the Glut1mRNA. The p44 cis-element causes destabilization of
the Glut1 transcript, and is associated with an endonuclease/exonuclease
activity. The proposed work is comprised of 3 specific aims. Fist, the
mechanism of post-transcriptional regulation of Glut1 gene expression will be
further defined using a luciferase reporter gene, and cells will also be stably
transfected with the Glut1 gene containing selective deletions of th4 putative
cis-elements within 3'-UTR. The stably transfected cells will be subjected to
hypoxia and glucose deprivation in tissue culture. In parallel, in vivo studies
of regional cerebral ischemia using the middle cerebral artery occlusion (MCAO)
model as well as global cereal ischemia, using the transient forebrain ischemia
(TFI) model, will be performed and correlations will be made between polysome
p44, cytosol p88, and Glut1 mRNA levels in whole brain and polysomes,
immunoreacitve Glut1 protein, both in brain and at the BBB in vivo. Second,
cDNAs encoding the glut1 mRNA UTR-binding proteins will be cloned, sequenced,
and analyzed, in parallel with cloning of cDNAs encoding non-glut1 transcripts
expressing the cis-acting elements found in the glut1 mRNA 3'-UTR. Third, the
secondary structure of the Glut1 mRNA both with and without binding to the p44
and p88 proteins will be determined experimentally using both chemical and
enzymatic approaches. These studies will provide insight into molecular
mechanisms of regulation of a step crucial to the maintenance of cerebral
intermediary metabolism, i.e., the continuous transport of glucose across the
blood-brain barrier in vivo.
描述:(逐字摘自申请人的摘要)主要的葡萄糖
脑毛细血管内皮细胞的转运蛋白,它构成了血脑
体内屏障(BBB)是钠非依赖性葡萄糖的Glut1亚型
转运蛋白基因家族。以往的研究已经证明了一种重要的模式
对于血脑屏障Glut1基因表达的调节是在转录后
人脑肿瘤、血糖等病理生理状态的水平
剥夺/低血糖、发育和脑缺血。
转录后调节mRNA的功能是通过
胞质或多聚体蛋白与特定顺式元件的相互作用
位于Glut1的5‘或3’非翻译区(UTR)内
MRNA.以前的研究已经描述了一种多聚体蛋白,命名为p44,以及一种
胞浆蛋白,命名为P88,它与两个不同的
Glout1基因3‘端非编码区中的顺式元件。P88顺式元件是
与Glut1基因表达增加相关,并介导
Glut1mRNA的稳定化。P44顺式元件导致不稳定
Glut1转录本,与核酸内切酶/核酸外切酶相关
活动。拟议的工作由三个具体目标组成。第一,拳头
转录后调节Glut1基因表达的机制将是
进一步定义使用荧光素酶报告基因,细胞也将稳定
含有TH4选择性缺失的Glut1基因的转染
3‘-非编码区内的顺式元件。稳定转染的细胞将受到
组织培养中的低氧和缺糖。同时,活体研究
大脑中动脉阻塞(MCAO)对局灶性脑缺血的诊断价值
利用短暂性前脑缺血模型和全脑缺血模型
(TFI)模型,并将在多聚体之间进行关联
全脑和多聚体中P44、胞浆P88和Glut1的mRNA水平,
Glut1蛋白在脑内和体内的血脑屏障中均呈免疫反应。第二,
将克隆编码Glut1 mRNA UTR结合蛋白的cDNA,对其进行测序,
并在克隆编码非Glut1转录本的cDNA的同时进行了分析
表达Glut1mRNA3‘-UTR中的顺式作用元件。第三,
与p44结合和不结合的Glut1基因的二级结构
和P88蛋白将通过实验确定使用化学和
酶促方法。这些研究将为我们深入了解分子
对维持脑功能至关重要的一步的调节机制
中间代谢,即葡萄糖在体内的持续运输。
体内的血脑屏障。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Molecular biology of the blood-brain barrier.
血脑屏障的分子生物学。
- DOI:10.1385/1-59259-419-0:385
- 发表时间:2003
- 期刊:
- 影响因子:0
- 作者:Pardridge,WilliamM
- 通讯作者:Pardridge,WilliamM
Amplification of blood-brain barrier GLUT1 glucose transporter gene expression by brain-derived peptides.
脑源性肽放大血脑屏障 GLUT1 葡萄糖转运蛋白基因表达。
- DOI:10.1016/s0168-0102(01)00246-2
- 发表时间:2001
- 期刊:
- 影响因子:2.9
- 作者:Boado,RJ
- 通讯作者:Boado,RJ
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WILLIAM M PARDRIDGE其他文献
WILLIAM M PARDRIDGE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WILLIAM M PARDRIDGE', 18)}}的其他基金
Antisense imaging of brain gene expression in vivo
体内脑基因表达的反义成像
- 批准号:
6897018 - 财政年份:2002
- 资助金额:
$ 22.16万 - 项目类别:
Antisense imaging of brain gene expression in vivo
体内脑基因表达的反义成像
- 批准号:
6435636 - 财政年份:2002
- 资助金额:
$ 22.16万 - 项目类别:
Antisense imaging of brain gene expression in vivo
体内脑基因表达的反义成像
- 批准号:
6656880 - 财政年份:2002
- 资助金额:
$ 22.16万 - 项目类别:
Antisense imaging of brain gene expression in vivo
体内脑基因表达的反义成像
- 批准号:
6894945 - 财政年份:2002
- 资助金额:
$ 22.16万 - 项目类别:
BLOOD BRAIN BARRIER LARGE NEUTRAL AMINO ACID TRANSPORTER
血脑屏障大型中性氨基酸转运蛋白
- 批准号:
6651028 - 财政年份:2000
- 资助金额:
$ 22.16万 - 项目类别:
AIDS THERAPEUTICS & BLOOD-BRAIN BARRIER AZT DRUG EFFLUX
艾滋病治疗
- 批准号:
6392722 - 财政年份:2000
- 资助金额:
$ 22.16万 - 项目类别:
AIDS THERAPEUTICS & BLOOD-BRAIN BARRIER AZT DRUG EFFLUX
艾滋病治疗
- 批准号:
6539049 - 财政年份:2000
- 资助金额:
$ 22.16万 - 项目类别:
AIDS THERAPEUTICS & BLOOD-BRAIN BARRIER AZT DRUG EFFLUX
艾滋病治疗
- 批准号:
6145728 - 财政年份:2000
- 资助金额:
$ 22.16万 - 项目类别:
相似海外基金
Establishment of a Mouse NK Cell Line for Analyzing Tumor Infiltration Processes and Developing a Preclinical Model for Cancer Immunotherapy.
建立小鼠 NK 细胞系,用于分析肿瘤浸润过程并开发癌症免疫治疗的临床前模型。
- 批准号:
23K06731 - 财政年份:2023
- 资助金额:
$ 22.16万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Proof of usefulness of PDX derived cell line
PDX 衍生细胞系的有用性证明
- 批准号:
23K06616 - 财政年份:2023
- 资助金额:
$ 22.16万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A novel producer cell line for more efficient manufacturing of viral vector systems
用于更有效地制造病毒载体系统的新型生产细胞系
- 批准号:
10597799 - 财政年份:2023
- 资助金额:
$ 22.16万 - 项目类别:
Genestorian: a web application to document and trace genetic modifications in model organism and cell line collections.
Genestorian:一个网络应用程序,用于记录和追踪模型生物和细胞系集合中的遗传修饰。
- 批准号:
EP/Y024591/1 - 财政年份:2023
- 资助金额:
$ 22.16万 - 项目类别:
Fellowship
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10672364 - 财政年份:2022
- 资助金额:
$ 22.16万 - 项目类别:
Developing a stable cell line expressing recombinant sclerostin
开发表达重组硬化素的稳定细胞系
- 批准号:
10385037 - 财政年份:2022
- 资助金额:
$ 22.16万 - 项目类别:
Development of Natural Killer (NK) Cell Line-Derived Extracellular Vesicles as a New Treatment for Cancer
开发自然杀伤 (NK) 细胞系衍生的细胞外囊泡作为癌症的新治疗方法
- 批准号:
10383462 - 财政年份:2022
- 资助金额:
$ 22.16万 - 项目类别:
A cell culture management platform to improve biomedical reproducibility by combining cell line tracking, low-cost genetic analysis, and riskassessment
细胞培养管理平台,通过结合细胞系追踪、低成本遗传分析和风险评估来提高生物医学重现性
- 批准号:
10483063 - 财政年份:2022
- 资助金额:
$ 22.16万 - 项目类别:
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10546865 - 财政年份:2022
- 资助金额:
$ 22.16万 - 项目类别:
Modulating expression of candidate genes to improve lentiviral vector production in stable cell line
调节候选基因的表达以提高稳定细胞系中慢病毒载体的产量
- 批准号:
2752732 - 财政年份:2022
- 资助金额:
$ 22.16万 - 项目类别:
Studentship